PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-145 Cr |
| Mar2024 | ₹-157 Cr |
| Mar2023 | ₹-130 Cr |
| Mar2022 | ₹-105 Cr |
| Mar2021 | ₹-22 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-145 Cr | Negative | |
| Mar2024 | ₹-157 Cr | Negative | |
| Mar2023 | ₹-130 Cr | Negative | |
| Mar2022 | ₹-105 Cr | Negative | |
| Mar2021 | ₹-22 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,473.9 Cr | -3.3% | -8.8% | -20.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -3.3% |
-8.8% |
-20.9% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses